Atrioventricular (AV) Valves Summit 2023
Published: 03 November 2023
-
Views:
3852
-
Likes:
7
-
Views:
3852
-
Likes:
7
-
5m 39sPart 4 | Session 1 TEER in the UK: Insights into its Origins, Progress and Future Prospects -
8mPart 4 | Session 2 TEER vs TAVI: Bridging the Gap in Potential Undertreatment
-
4m 37sPart 6 AV Valves Summit at a Glance
-
10m 34sPart 1 | Session 1 Summit Overview and Optimising MR and TR Treatments Francesco Maisano, Marta Sitges
-
10m 41sPart 1 | Session 2 Summit Overview: Trending Topics in AV Valves Ralph Stephan von Bardeleben
-
14m 15sPart 2 Mitral and Tricuspid Learnings Lluis Asmarats, Tomás Benito González
Overview
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcatheter mitral and tricuspid intervention.
They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment.
The AV Valves Summit led by course directors Prof Francesco Maisano (San Raffaele Hospital, Milan, IT), Prof Marta Sitges (University of Barcelona, Barcelona, ES), Prof Marco Metra (University of Brescia, Brescia, IT) and Prof Ralph Stephan von Bardeleben (University Medical Center of Mainz, Mainz, DE) provided a platform to advance knowledge and shape the trajectory of this treatment in cardiovascular healthcare.
Learning Objectives
- Gain an understanding of the anatomy of mitral and tricuspid valves to inform appropriate intervention strategies
- The importance of incorporating quality of life considerations into patient management plans, aiming to improve the overall well-being of individuals undergoing valve interventions
- Learn to identify, prevent, and manage complications associated with mitral and tricuspid valve interventions to ensure patient safety
- Explore evidence-based strategies for decision-making in heart failure management
- Assess emerging trends and future innovations impacting the trajectory of mitral and tricuspid valve therapies
Target audience
- Interventional Cardiologist
- Echocardiographer
- Heart Failure Specialist
- Cardiac Surgeon
More from this programme
Part 1
Course Directors
Part 2
Mitral and Tricuspid Learnings
| 1 session | |
| Mitral and Tricuspid Learnings | Watch now |
Part 3
Exploring Controversies
Part 4
Exploring Transcatheter Edge to Edge Repair
Part 5
RMS en France
Part 6
AV Valves Summit at a Glance
| 1 session | |
| AV Valves Summit at a Glance | Watch now |
Faculty Biographies
Niklas Schofer
Interventional cardiologist
Dr Niklas Schofer is an interventional cardiologist at the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg, DE. He is a renowned specialist in Cardiology with a primary focus on Structural Heart interventions, including MitraClip and TAVI procedures. He plays a pivotal role in advancing cardiac care, exemplifying excellence in patient management and research.
Tobias Ruf
Divisional Head Structural Heart Clinical Studies and Divisional Head AV-Valves and Occluder Interventions
Dr Tobias Ruf is Senior Physician for Structural Heart Diseases at the Heart Valve Center within the University Medical Center Mainz, DE. He also holds the position of Deputy Senior Physician and is a board-certified specialist in Internal Medicine, specialising in Cardiology. His research interests focus on advancing cardiac care, particularly in structural heart diseases. Dr Ruf's expertise contributes significantly to the ongoing success of the University Medical Center Mainz's cardiology department.